Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcomeof 24 patients treated at a Tertiary Care Center in Saudi Arabia
Author(s) -
Shahid Iqbal,
Syed Ziauddin A. Zaidi,
Ibraheem Motabi,
Nawal F Alshehry,
Mubarak S. AlGhamdi,
Imran K Tailor
Publication year - 2016
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.326.11274
Subject(s) - medicine , thrombotic thrombocytopenic purpura , rituximab , tertiary care , microangiopathic hemolytic anemia , refractory (planetary science) , thrombocytopenic purpura , retrospective cohort study , pediatrics , surgery , platelet , physics , lymphoma , astrobiology
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease. The primary aim was overall response rate (ORR) assessment in the treated patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom